119 related articles for article (PubMed ID: 2952300)
1. Neocarzinostatin: carboxyl-terminal-43-peptide residue of apo-neocarzinostatin as the binding site of neocarzinostatin-chromophore.
Edo K; Saito K; Akiyama Y; Mizugaki M; Koide Y; Ishida N
Chem Pharm Bull (Tokyo); 1986 Dec; 34(12):5180-3. PubMed ID: 2952300
[No Abstract] [Full Text] [Related]
2. An antitumor polypeptide antibiotic neocarzinostatin: the mode of apo-protein--chromophore interaction.
Edo K; Saito K; Akiyama-Murai Y; Mizugaki M; Koide Y; Ishida N
J Antibiot (Tokyo); 1988 Apr; 41(4):554-62. PubMed ID: 2967272
[TBL] [Abstract][Full Text] [Related]
3. Characterization of secondary structure of neocarzinostatin apoprotein.
Saito K; Sato Y; Edo K; Akiyama-Murai Y; Koide Y; Ishida N; Mizugaki M
Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3078-82. PubMed ID: 2534360
[TBL] [Abstract][Full Text] [Related]
4. [Mechanisms of actions of neocarzinostatin (NCS) and NCS-associated nonprotein chromophore (author's transl)].
Ohtsuki K; Ishida N
Tanpakushitsu Kakusan Koso; 1981 Jun; 26(7):937-49. PubMed ID: 6457319
[No Abstract] [Full Text] [Related]
5. Neocarzinostatin: selective tryptophan oxidation and neocarzinostatin-chromophore binding to apo-neocarzinostatin.
Edo K; Saito K; Matsuda Y; Akiyama-Murai Y; Mizugaki M; Koide Y; Ishida N
Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):170-6. PubMed ID: 1828722
[TBL] [Abstract][Full Text] [Related]
6. Production of a free chromophore component of neocarzinostatin (NCS) in the culture filtrate of Streptomyces carzinostaticus var. F-41.
Kudo K; Suto T; Koide Y; Edo K; Ishida N
J Antibiot (Tokyo); 1982 Aug; 35(8):1111-5. PubMed ID: 6216232
[No Abstract] [Full Text] [Related]
7. Radioimmunoassays for methotrexate, citrovorum factor, neocarzinostatin, and actinomycin D.
Raso V
Cancer Treat Rep; 1977 Jul; 61(4):585-90. PubMed ID: 141980
[TBL] [Abstract][Full Text] [Related]
8. Naphthalenecarboxylic acid from neocarzinostatin (NCS).
Edo K; Katamine S; Kitame F; Ishida N; Koide Y; Kusano G; Nozoe S
J Antibiot (Tokyo); 1980 Mar; 33(3):347-51. PubMed ID: 6445890
[No Abstract] [Full Text] [Related]
9. Neocarzinostatin chromophore. Assignment of spectral properties and structural requirements for binding to DNA.
Napier MA; Goldberg IH
Mol Pharmacol; 1983 Mar; 23(2):500-10. PubMed ID: 6220205
[TBL] [Abstract][Full Text] [Related]
10. Extra-weak chemiluminescence of drugs. IX. Extra-weak chemiluminescence of neocarzinostatin injection.
Edo K; Saito K; Kato M; Akiyama-Murai Y; Sato H; Mizugaki M
Chem Pharm Bull (Tokyo); 1988 Nov; 36(11):4603-7. PubMed ID: 2977573
[No Abstract] [Full Text] [Related]
11. Fluorophotometric enzyme immunoassay of neocarzinostatin using peroxidase as a label.
Matsuoka K; Maeda M; Tsuji A
Chem Pharm Bull (Tokyo); 1980 Jun; 28(6):1864-8. PubMed ID: 6447549
[No Abstract] [Full Text] [Related]
12. Detection of neocarzinostatin chromophore-deoxyribose adducts as exonuclease-resistant sites in defined-sequence DNA.
Povirk LF; Goldberg IH
Biochemistry; 1985 Jul; 24(15):4035-40. PubMed ID: 2996589
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of a novel chromoprotein derived from apo-neocarzinostatin and a synthetic chromophore.
Urbaniak MD; Muskett FW; Finucane MD; Caddick S; Woolfson DN
Biochemistry; 2002 Oct; 41(39):11731-9. PubMed ID: 12269815
[TBL] [Abstract][Full Text] [Related]
14. Isolation of a non-protein component and a protein component from neocarzinostatin (NCS) and their biological activities.
Koide Y; Ishii F; Hasuda K; Koyama Y; Edo K; Kitamine S; Kitame F; Ishida N
J Antibiot (Tokyo); 1980 Mar; 33(3):342-6. PubMed ID: 6445889
[No Abstract] [Full Text] [Related]
15. Structure of the antitumor protein neocarzinostatin. Amino acid sequence.
Maeda H; Glaser CB; Kuromizu K; Meienhofer J
Arch Biochem Biophys; 1974 Oct; 164(2):379-85. PubMed ID: 4282219
[No Abstract] [Full Text] [Related]
16. Isolation and fast purification of neocarzinostatin by FPLC-ion exchange chromatography.
Denklau D; Köhnlein W; Lüders G; Stellmach J
Z Naturforsch C Biosci; 1983; 38(11-12):939-42. PubMed ID: 6230805
[TBL] [Abstract][Full Text] [Related]
17. Urea treatment and pronase digestion of antitumor protein antibiotics, auromomycin and neocarzinostatin.
Suzuki H; Ozawa S; Tanaka N
J Antibiot (Tokyo); 1980 Dec; 33(12):1545-50. PubMed ID: 6454671
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of apo-neocarzinostatin at 0.15-nm resolution.
Teplyakov A; Obmolova G; Wilson K; Kuromizu K
Eur J Biochem; 1993 Apr; 213(2):737-41. PubMed ID: 8477746
[TBL] [Abstract][Full Text] [Related]
19. Key interactions in the immunoglobulin-like structure of apo-neocarzinostatin: evidence from nuclear magnetic resonance relaxation data and molecular dynamics simulations.
Izadi-Pruneyre N; Quiniou E ; Blouquit Y; Perez J; Minard P; Desmadril M; Mispelter J; Adjadj E
Protein Sci; 2001 Nov; 10(11):2228-40. PubMed ID: 11604530
[TBL] [Abstract][Full Text] [Related]
20. Roles of chromophore and apo-protein in neocarzinostatin action.
Kappen LS; Napier MA; Goldberg IH
Proc Natl Acad Sci U S A; 1980 Apr; 77(4):1970-4. PubMed ID: 6445563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
